Al Harbi O - Search Results

1

Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study.

Yamamoto-Furusho JK, Al Harbi O, Armuzzi A, Chan W, Ponce de Leon E, Qian J, Shapina M, Toruner M, Tu CH, Ye BD, Guennec M, Sison C, Demuth D, Fadeeva O, Khan QMR. Yamamoto-Furusho JK, et al. Among authors: al harbi o. Dig Liver Dis. 2020 Aug;52(8):869-877. doi: 10.1016/j.dld.2020.05.031. Epub 2020 Jun 17. Dig Liver Dis. 2020. PMID: 32563721 Free article.

2

A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease.

Mosli MH, Al-Harbi O, Feagan BG, Almadi MA. Mosli MH, et al. Among authors: al harbi o. Saudi J Gastroenterol. 2015 Jul-Aug;21(4):185-97. doi: 10.4103/1319-3767.161635. Saudi J Gastroenterol. 2015. PMID: 26228361 Free PMC article.

3

Plasma ghrelin and leptin in patients with inflammatory bowel disease and its association with nutritional status.

Ghomraoui FA, Alotaibi ST, Alharthi MA, Asiri SS, Almadi MA, Alharbi OR, Azzam NA, Aljebreen AM, Saeed M, Hajkhder B, Saeed W, Alzoghaibi MA. Ghomraoui FA, et al. Saudi J Gastroenterol. 2017 May-Jun;23(3):199-205. doi: 10.4103/sjg.SJG_575_16. Saudi J Gastroenterol. 2017. PMID: 28611344 Free PMC article.

4

Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn's disease treated with antitumor necrosis factor-alpha agents based on Parks' classification.

Azzam N, Alharbi O, Almadi M, Aljebreen A, AlAmeel T, Alabbas M, Bahammam S, Bashmail A, Alomar Y, Mosli M. Azzam N, et al. Eur J Gastroenterol Hepatol. 2020 Feb;32(2):187-192. doi: 10.1097/MEG.0000000000001634. Eur J Gastroenterol Hepatol. 2020. PMID: 31851087

5

A cross-sectional survey on the psychological impact of the COVID-19 pandemic on inflammatory bowel disease patients in Saudi Arabia.

Mosli M, Alourfi M, Alamoudi A, Hashim A, Saadah O, Al Sulais E, AlAmeel T, Alharbi O, Bakari S, Meeralam Y, Alshobai S, Alsahafi M, Jawa H, Qari Y. Mosli M, et al. Saudi J Gastroenterol. 2020 Sep-Oct;26(5):263-271. doi: 10.4103/sjg.SJG_220_20. Saudi J Gastroenterol. 2020. PMID: 32567580 Free PMC article.

6

The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia.

AlRuthia Y, Almadi M, Aljebreen A, Azzam N, Alsharif W, Alrasheed H, Almuaythir G, Saeed M, HajkhderMullaissa B, Alharbi O. AlRuthia Y, et al. J Med Econ. 2020 Oct;23(10):1102-1110. doi: 10.1080/13696998.2020.1791889. Epub 2020 Jul 23. J Med Econ. 2020. PMID: 32619388 Free article.

7

Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.

Azzam N, AlRuthia Y, Alharbi O, Aljebreen A, Almadi M, Loftus EV Jr. Azzam N, et al. Hepatol Int. 2020 Dec;14(6):1114-1124. doi: 10.1007/s12072-020-10110-5. Epub 2020 Dec 28. Hepatol Int. 2020. PMID: 33369708

8

Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort.

Azzam N, Aljebreen A, Alharbi O, Charabaty A, Alanazi M, Alkuwaykibi N, Alfaraidi J, Bashamil A, Almansour T, Almadi M. Azzam N, et al. Arab J Gastroenterol. 2021 Mar;22(1):66-72. doi: 10.1016/j.ajg.2021.01.001. Epub 2021 Feb 23. Arab J Gastroenterol. 2021. PMID: 33632623

9

Clinical characteristics, natural history, and outcomes of Crohn's-related intra-abdominal collections.

Alharbi O, Almadi MA, Azzam N, Aljebreen AM, AlAmeel T, Schreiber S, Mosli MH. Alharbi O, et al. Saudi J Gastroenterol. 2021 Mar-Apr;27(2):79-84. doi: 10.4103/sjg.SJG_89_20. Saudi J Gastroenterol. 2021. PMID: 33723092 Free PMC article.

10

Prevalence, severity and associated factors of restless leg syndrome in inflammatory bowel disease patients.

AlHarbi OR, Bahammam A, Olaish AH, Azzam NA, Aljebreen AA, Almadi MA, Alsaleh SA. AlHarbi OR, et al. Saudi J Gastroenterol. 2021 Nov-Dec;27(6):348-354. doi: 10.4103/sjg.sjg_642_20. Saudi J Gastroenterol. 2021. PMID: 34596594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters